Mental Health R&D: A Global Priority
Dear colleagues and friends,
We are delighted to announce our next complimentary global event – Mental Health R&D: A Global Priority – will take place on October 10, 2022, the World Mental Health Day, as we gather some of the world’s leading researchers, drug developers, and clinicians to critically examine the state of treatment, and better align our R&D efforts to WHO’s initiative in Making Mental Health & Well-Being for All a Global Priority.
Our featured speakers include:
• John Krystal, Chair, Department of Psychiatry; Robert L. McNeil, Jr. Professor of Translational Research, Yale University
• Murali Gopalakrishnan, Global Head, Neuroscience Search & Evaluation, Corporate Strategy Office, AbbVie
• Ben Robbins, General Partner, GV
This will be the 11th episode of WuXi AppTec’s “Collaborations That Transform” series highlighting the importance of working collaboratively to solve industry-wide problems so that we can bring transformational medicines faster to patients. In this spirit, we hosted a series of events in 2022 including Rising to the Challenge: Healthy Aging Forum 2022, Fragile X Syndrome: Innovative Approaches to Finding a Cure, Moving the Needle on ALS & Neuromuscular Disorders, WuXi Global Forum 2022, and WuXi Healthcare Forum 2022.
For the convenience of our global audience, this program will premiere on October 10 from 8am PDT – 10am PDT and from 7pm PDT – 9pm PDT. We will share an on-demand link with registrants after the event for those who were not able to attend the live premiere.